Business Description
Hemostemix Inc
NAICS : 325412
SIC : 3741
ISIN : CA4236941080
Compare
Compare
Traded in other countries / regions
HEM.CanadaHMTXF.USA2VF0.Germany IPO Date
2012-12-20Description
Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company's clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.09 | |||||
| Equity-to-Asset | -9.78 | |||||
| Debt-to-Equity | -0.63 | |||||
| Debt-to-EBITDA | -1.93 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 41.6 | |||||
| 3-Year EPS without NRI Growth Rate | 37.7 | |||||
| 3-Year FCF Growth Rate | 27.4 | |||||
| 3-Year Book Growth Rate | 30.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 3.88 | |||||
| 9-Day RSI | 17.03 | |||||
| 14-Day RSI | 27.34 | |||||
| 6-1 Month Momentum % | -31.82 | |||||
| 12-1 Month Momentum % | -54.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.25 | |||||
| Quick Ratio | 0.25 | |||||
| Cash Ratio | 0.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -71.4 | |||||
| Shareholder Yield % | -73.23 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -503.5 | |||||
| ROIC % | -7762.14 | |||||
| ROC (Joel Greenblatt) % | -222100 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -3.79 | |||||
| EV-to-EBITDA | -3.79 | |||||
| EV-to-FCF | -4.31 | |||||
| Earnings Yield (Greenblatt) % | -26.4 | |||||
| FCF Yield % | -45.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hemostemix Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.037 | ||
| Beta | 0.56 | ||
| Volatility % | 45.59 | ||
| 14-Day RSI | 27.34 | ||
| 14-Day ATR (C$) | 0.003048 | ||
| 20-Day SMA (C$) | 0.06 | ||
| 12-1 Month Momentum % | -54.55 | ||
| 52-Week Range (C$) | 0.05 - 0.175 | ||
| Shares Outstanding (Mil) | 89.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hemostemix Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hemostemix Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hemostemix Inc Frequently Asked Questions
What is Hemostemix Inc(TSXV:HEM)'s stock price today?
The current price of TSXV:HEM is C$0.05. The 52 week high of TSXV:HEM is C$0.18 and 52 week low is C$0.05.
When is next earnings date of Hemostemix Inc(TSXV:HEM)?
The next earnings date of Hemostemix Inc(TSXV:HEM) is .
Does Hemostemix Inc(TSXV:HEM) pay dividends? If so, how much?
Hemostemix Inc(TSXV:HEM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers